Burzynski Resh Inst Stock Price, News & Analysis
Company Description
Burzynski Resh Inst (OTC Link: BZYR) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $1.4M.
BZYR stock has declined 69.1% over the past year. Shares last traded at $0.0108.
On a trailing twelve-month basis, Burzynski Resh Inst reported revenue of $0 and diluted earnings per share of $-0.01.
This page provides a comprehensive overview of BZYR stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Burzynski Resh Inst (BZYR) stock last traded at $0.0108. Over the past 12 months, the stock has lost 69.1%. At a market capitalization of $1.4M, BZYR is classified as a micro-cap stock with approximately 131.4M shares outstanding.
BZYR Rankings
Latest News
SEC Filings
Burzynski Resh Inst has filed 7 recent SEC filings, including 3 Form 8-K/A, 2 Form 8-K, 2 Form 10-Q. The most recent filing was submitted on May 12, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BZYR SEC filings →
Financial Highlights
Diluted earnings per share stood at $-0.01.
Upcoming Events
Short Interest History
Short interest in Burzynski Resh Inst (BZYR) currently stands at 285 shares, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 83.8%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Burzynski Resh Inst (BZYR) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
BZYR Company Profile & Sector Positioning
Burzynski Resh Inst (BZYR) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.